Oral Abstract Session:
97. Vaccines for all Ages
Friday, October 4, 2013: 8:30 AM-10:00 AM
Room: The Moscone Center: 200-212

Learning Objectives:

-

Target Audience: infectious diseases physicians

Topical Category: V. Clinical Virology

Tracks: Pediatric ID, Adult ID

Moderator:  Tina Tan, MD, FIDSA, Northwestern University Feinberg School of Medicine

Presentations:

8:45 AM
639
LONG-TERM STUDIES OF QUADRIVALENT HPV (qHPV) VACCINE EFFECTIVENESS
Anna-Barbara Moscicki, MD ; Alfred Saah, MD

9:00 AM
640
Assessment of the Novel Oral Typhoid Vaccine Candidate, M01ZH09, Using a Controlled Human Infection Model of Salmonella Typhi Challenge
Tom Darton, MRCP(UK), DTM&H ; Claire Waddington, MRCP(UK), DPhil ; Claire Jones, PhD ; Christoph Blohmke, PhD ; Rebecca Sie, BSc ; Anna Peters ; Gordon Dougan, FMedSci, FRS ; Robert Kingsley, PhD ; Stephen Lockhart, DM ; Marcelo Sztein, M.D. ; Myron Levine, MD, FIDSA ; Jeremy Farrar, MD, PhD ; Derrick Crook, MB BCh ; Brian Angus ; Andrew Pollard, FRCPCH, PhD

9:15 AM
641
Differential Circulation Patterns of Oral Polio Vaccine Serotypes 1, 2, and 3 after Mexican National Immunization Weeks
Stephanie Troy, MD ; Leticia Ferreyra-Reyes, MD ; ChunHong Huang, MS ; Sergio Canizales-Quintero ; Christine Nelson ; Renata Báez-Saldaña, MD ; Elizabeth Ferreira-Guerrero, MD ; Lourdes García-García, MD ; Yvonne Maldonado, MD, FIDSA

9:30 AM
642
Rotavirus Vaccination in Neonatal Intensive Care Units (NICUs): Safety and Feasibility
Samuel Thrall, MDCM (c) ; Milagros Gonzales, MSc ; Philippe Lamer, NNP MSc ; Gabrielle Girard, B. Pharm MSc ; Thérèse Perreault, MD ; Caroline Quach, MD MSc

9:45 AM
643
Using an Immunization Information System (IIS) to Estimate the Effectiveness of Tdap in Preventing Pertussis During a Large Outbreak, Wisconsin, July 2011-December 2012
Ruth Koepke, MPH ; Jens Eickhoff, PhD ; Roman Aydiko Ayele, MPH ; Ashley Richardson-Haleem, MPH ; Stephanie Schauer, PhD ; Thomas Maerz ; Daniel Hopfensperger, BS ; James Conway, MD FAAP ; Jeffrey Davis, MD

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

T. Tan, Merck: Grant Investigator, Grant recipient and Research grant

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.